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Infectious bovine keratoconjunctivitis (IBK) is a highly contagious ocular disease that affects cattle of all
ages and that occurs worldwide. Piliated hemolytic Moraxella bovis is recognized as the etiologic agent of IBK.
According to data from the Nebraska Veterinary Diagnostic Laboratory System, however, Moraxella (Branha-
mella) ovis has been isolated with increasing frequency from cattle affected with IBK. The objective of this study
was, therefore, to examine M. ovis field isolates for the presence of the putative virulence factors of M. bovis.
Culture filtrates from selected M. ovis field isolates demonstrated hemolytic activity on bovine erythrocytes and
cytotoxic activity on bovine peripheral blood mononuclear cells and corneal epithelial cells. The hemolytic
activity of the culture filtrates was attenuated after heat treatment. Polyclonal antibodies raised against the M.
bovis hemolysin-cytotoxin also recognized a protein of approximately 98 kDa in a Western blot assay. These
data indicate that the M. ovis field isolates examined produce one or more heat-labile exotoxins and may
suggest that M. ovis plays a role in the pathogenesis of IBK.
Infectious bovine keratoconjunctivitis (IBK) is a highly con-
tagious disease that affects cattle of all ages and that occurs
worldwide (27, 28, 31). The adverse economic impact of IBK
due to decreased weight gain and costs of therapeutic treat-
ment is estimated to be $150 million annually (27). Piliated
hemolytic strains of Moraxella bovis are recognized as the eti-
ologic agents of IBK (5, 10, 11, 23, 35, 36, 37). Moraxella bovis,
however, cannot always be recovered from clinical cases; and
other organisms, such as Moraxella (Branhamella) ovis, Myco-
plasma bovoculi, infectious bovine rhinotracheitis virus, and
adenovirus, have been suggested to play a role in the patho-
genesis of IBK (17, 19, 31, 37).
According to data of the University of Nebraska Veterinary
Diagnostic Laboratory System, M. ovis is isolated with increas-
ing frequency from cases of IBK. From 1999 to 2002, M. ovis
was isolated three times more often from field cases than M.
bovis. Isolation of M. ovis from cases of keratoconjunctivitis has
previously been reported in sheep, goats, deer, and moose (3,
14, 16, 17, 30, 33, 40, 41). In cattle, M. ovis has been isolated
from IBK cases (17, 31); but the significance of its isolation is
currently unclear because, in one study, experimental inocula-
tion of calves with M. ovis isolated did not cause keratocon-
junctivitis (17). These findings suggest that M. ovis is not a
pathogen or that additional factors may be required for viru-
lence (9, 17, 32, 43).
Isolates of M. ovis recovered from cattle with IBK have not
been examined for potential virulence factors (6, 21, 26, 34,
39). In an attempt to elucidate whether M. ovis plays a role in
the etiology and pathogenesis of IBK, the objective of this
study was to investigate M. ovis field isolates for the presence
of factors known to be virulence factors in M. bovis by exam-
ining the effects of M. ovis culture filtrates on different types of
cells of bovine origin.
MATERIALS AND METHODS
Bacterial isolates. Moraxella ovis isolates recovered from cattle with IBK were
passed twice on Trypticase soy agar containing 5% sheep blood (blood agar;
Remel, Lenexa, KS) and were stored at 80°C in 15% glycerol. A known virulent
isolate of M. bovis, designated Epp63 (20, 35, 36), and a reference isolate of M.
ovis (ATCC 19575) recovered from a sheep with conjunctivitis were used in each
assay for comparison. Field isolates of M. ovis were identified by phenotypic and
biochemical criteria. Briefly, M. ovis colonies were 1 to 3 mm in diameter after
24 h of incubation, firm, and hemolytic on blood agar; and they tended to slide
across the agar surface when they were touched with a Nichrome wire loop.
Microscopically, the M. ovis isolates were gram-negative cocci (0.6 to 1.0 m)
arranged in pairs. All M. ovis isolates were aerobic and oxidase and catalase
positive, and they reduced nitrate but did not ferment carbohydrates or liquefy
gelatin (8, 13, 22, 30).
Preparation of culture supernatants. Aliquots of each isolate from frozen
stock cultures were streaked onto blood agar and incubated at 37°C for 24 h.
Culture for hemolysin production during early-logarithmic-phase growth was
performed as described previously (20) but with modification. Briefly, three
colonies of each isolate from the blood agar plate were transferred into 3 ml of
brain heart infusion (BHI) broth (Remel) supplemented with 5 mM CaCl2/ml
(Sigma Chemical Company, St. Louis, MO), and the cultures were incubated for
18 h at 37°C. The cultures were then transferred to Erlenmeyer flasks containing
50 ml of BHI broth supplemented with 5 mM CaCl2/ml and were incubated with
shaking (200 rpm) for 4.5 h at 37°C. The bacterial cells were removed by
centrifugation (12,000  g) for 10 min at 4°C, and the culture supernatants were
transferred to sterile centrifuge tubes. Each supernatant was filtered through a
0.22-l polysulfone syringe filter (Pall Gelman Laboratory, Ann Arbor, MI), and
the cell-free supernatants (CFSs) were either used immediately or frozen at
80°C until use. An aliquot of each CFS was plated on blood agar to verify
sterility.
Hemolytic activity assay. Bovine erythrocytes were washed three times with
sterile phosphate-buffered saline (PBS), and a 10% erythrocyte suspension was
* Corresponding author. Present address: GeneSeek, Inc., 4711 In-
novation Drive, Lincoln, NE 68521. Phone: (402) 435-0665. Fax: (402)
435-0664. E-mail: shinkley@geneseek.com.
† This article is published as ARD Journal Series number 13909,
with the approval of the University of Nebraska Agricultural Re-
search Division.
772
 at U
N
IV
 O
F
 N
E
B
R
A
S
K
A
-LIN
C
O
LN
 on A
ugust 30, 2007 
jcm
.asm
.org
D
ow
nloaded from
 
prepared in PBS and stored at 4°C for no longer than 3 days before use. The
hemolytic activity of each CFS was analyzed in 96-well microtiter plates as
described previously (20) but with modification. Briefly, twofold dilutions (1:2 to
1:2,048) of each sample were run in duplicate in 100 l of a 0.15 M sodium
chloride (Sigma) solution containing 10 mM Tris-Cl buffer (Sigma) and 10 mM
CaCl2 (Sigma) buffer (NTC buffer). Wells with distilled water served as positive
control wells, and wells with NTC buffer served as negative control wells. One
hundred microliters of 2% washed bovine erythrocytes in PBS was added to each
well, and the plates were incubated for 2 h at 37°C. Intact erythrocytes were
pelleted by centrifugation (1,500  g) for 5 min, and 100 l of each supernatant
was then transferred to a new plate. The absorbance (optical density [OD] at 410
nm) was determined for each well by using an enzyme-linked immunosorbent
assay reader (Molecular Devices Corporation, Sunnyvale, CA). The mean ab-
sorbance was calculated for each set of wells, and the titers were determined by
using the reciprocals of the last dilution with absorbance values above 5% of the
mean of the positive control wells.
To determine whether the hemolytic activity of M. ovis CFS was heat labile, 1
ml of each CFS was incubated in a water bath for 30 min at 56°C and was then
allowed to cool to room temperature. The hemolytic activity of each CFS was
then analyzed in 96-well microtiter plates as described above. In addition, each
CFS was stored at 4°C for 24 h and the hemolytic activity was determined as
described above.
Preparation of bovine PBMCs. Bovine peripheral blood mononuclear cells
(PBMCs) were prepared as described previously (20). Briefly, freshly collected
blood in EDTA was centrifuged (700  g) for 30 min at 4°C. The buffy coats were
removed and diluted with PBS, and the mixture was layered onto Ficoll-Paque
(Amersham Pharmacia Biotech, Uppsala, Sweden) and then centrifuged (700  g)
for 40 min at 4°C. The PBMCs were then collected from the interface, washed three
times in PBS containing 5 mM EDTA, and counted in a hemocytometer.
Cytotoxic activity assay. The density of the PBMCs was adjusted to a concen-
tration of 5  106 cells/ml for the dimethylthiazol diphenyltetrazolium bromide
(MTT) reduction cytotoxicity assay, and the cytoxic activity of each CFS was
determined in 96-well microtiter plates as described previously (20). Briefly,
twofold serial dilutions of each sample were run in duplicate in 100 l of 1
RPMI 1640 medium (Gibco BRL, Rockville, MD) supplemented with 10% fetal
calf serum. One hundred microliters of the PBMC suspension was added to each
well, and the plates were incubated for 1 h at 37°C. Following incubation, the
plates were centrifuged (700  g) for 5 min and the supernatant was discarded.
One hundred microliters of clear 1 RPMI 1640 medium and 20 l of MTT
(Sigma) dye solution (5 mg MTT in 1 ml distilled H2O) were then added to each
well, and plates were again incubated until a colored reaction product was visible
(2 to 4 h). The plates were then centrifuged (700  g) for 5 min, the supernatant
was discarded, and 100 l of acid isopropanol was added to each well. Gentle
agitation was used to dissolve the formazan precipitate. The absorbance of each
well was determined on an enzyme-linked immunosorbent assay reader by using
a test wavelength of 570 nm and a reference wavelength of 630 nm. The percent
cytotoxicity for each well was determined as follows: [1  (OD of toxin-treated
mononuclear cells/OD of untreated PBMCs)]  100. The untreated PBMCs
were used as cell viability controls.
The cytotoxic activity titer in each well was determined by using the reciprocal
of the highest dilution that caused the cytolysis of 50% or more of the target cells
compared to the level of cytolysis of the cells control wells. One hundred micro-
liters of the PBMC suspension and 100 l of RPMI 1640 medium were used to
assess cell viability, and 100 l of medium and 100 l of undiluted CFS were used
to assess nonspecific dye reduction.
Corneal epithelial cell culture. Corneas were collected from three clinically
healthy calves immediately following euthanasia. After removal of the globes and
the attached conjunctival sacs, the ocular tissues were briefly rinsed with 70%
ethyl alcohol and were then rinsed twice with sterile 0.85% saline solution. A
sterile scalpel blade was used to remove the cornea at the limbus, and the corneal
epithelium was dissected away from the underlying stroma. The corneal epithe-
lium was then rinsed three times in sterile 1 RPMI 1640 medium containing
0.003% gentamicin sulfate (Sigma). The corneal epithelium was minced with a
sterile scalpel blade in a sterile glass petri dish and then transferred to culture
flasks containing RPMI 1640 medium supplemented with 10% fetal calf serum
and 0.003% gentamicin sulfate (c-RPMI). The flasks were incubated at 37°C in
7% CO2 for 72 h. After incubation, the medium was decanted and the flasks were
washed once with warm (37°C) sterile PBS. Fresh c-RPMI medium was then
added to each flask, and the flasks were again incubated at 37°C in 7% CO2.
Fresh c-RPMI medium was added to each flask at 72-h intervals or until 100%
confluent cell monolayers had formed. The confluent cells were detached with
2.5% trypsin (Sigma), resuspended in c-RPMI, transferred to 96-well culture
plates, and incubated at 37°C in 7% CO2 for approximately 72 h or until 90%
confluent cell monolayers had formed in the wells.
Corneal epithelial cell cytotoxicity assay. Medium from each corneal epithelial
cell monolayer plate was discarded, and 10 l of fresh c-RPMI medium was
added to each well. Fifty microliters of a CFS was then added to each well, while
50 l of BHI broth was added to each control well. The plates were incubated at
37°C in 7% CO2 for 2 h. Medium from each plate was then discarded, and 200
l of fresh clear c-RPMI medium was added to each well. Each plate was then
examined at 400 magnification with an inverted microscope. The assay was
performed three times in duplicate.
Western blot analyses of M. bovis Epp63 and M. ovis CFS. CFS proteins from
two M. ovis field isolates, M. ovis ATCC 19575, and M. bovis Epp63 were
separated by standard 10% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE), as described previously (38), and then transferred to a
nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA). A kaleidoscope
prestained standard (Bio-Rad) was used to assess transfer efficiency. The non-
specific binding sites on the membrane were blocked with 1% fish gelatin
(Sigma) and 0.5% skim milk (Carnation) in PBS overnight at 4°C. The primary
antibody, a polyclonal rabbit serum raised against a partially purified extract of
hemolytic M. bovis strain T (2) (kindly provided by L. George, University of
California—Davis), was used at a 1:250 dilution in PBS. After 1 h of incubation
in primary antibody at ambient temperature, the membrane was washed (PBS
containing 500 l/liter Tween 20 [Bio-Rad]) and then incubated for 1 h in a
1:1,000 dilution of goat anti-rabbit immunoglobulin G horseradish peroxidase-
labeled conjugate (Promega, Madison, WI). Detection of bound secondary an-
tibody was by chemiluminescence (Pierce, Rockford, IL) and autoradiography.
Normal rabbit serum was substituted for anti-M. bovis antibodies as a negative
control in the protocol.
FIG. 1. Hemolytic activities of M. bovis and M. ovis isolates on bovine erythrocytes with and without heat treatment. Bars indicate the geometric
mean titers of the hemolytic activities of the CFSs from M. bovis Epp63, M. ovis ATCC 19575, and five M. ovis field isolates without heat treatment
(A). Heat treatment consisted of incubation of the CFSs at 56°C and cooling to room temperature prior to use in the hemolysin assay (B). Error
bars represent the 95% confidence intervals of the means. The results shown represent data from five independent replications of each set of
experiments.
VOL. 44, 2006 POTENTIAL VIRULENCE FACTORS OF MORAXELLA OVIS 773
 at U
N
IV
 O
F
 N
E
B
R
A
S
K
A
-LIN
C
O
LN
 on A
ugust 30, 2007 
jcm
.asm
.org
D
ow
nloaded from
 
RESULTS
Hemolytic activities of CFSs on bovine erythrocytes. The
CFSs from all isolates demonstrated hemolytic activities in the
assay, with titers ranging from 256 to 2,048 for the five M. ovis
field isolates and from 4,096 to 8,192 for the M. bovis Epp63
isolate (Fig. 1A). Heat treatment of the CFSs before the he-
molysin assay was conducted attenuated the hemolytic activity,
as the titers of the M. ovis CFSs observed after heat treatment
ranged only from 2 to 4 (Fig. 1B). This effect was also evident
when heat-treated and non-heat-treated CFSs were run side by
side for direct comparison (Fig. 2). In this series of assays,
non-heat-treated M. ovis CFSs had hemolytic activity titers of
1,024 to 2,048 that were reduced to titers of 2 to 4 after heat
treatment. Non-heat-treated M. bovis CFS titers were 4,096 to
8,192, and the titers after heat treatment were 8 to 32. When
the CFSs were stored at 4°C for 24 h prior to the assay,
hemolytic activity was reduced by three- to fourfold dilutions in
the M. ovis CFSs (titer range, 32 to 256) and one- to three fold
dilutions in the M. bovis Epp63 CFSs (titer range, 1,024 to
2,048) (data not shown). Because of the consistent hemolytic
activities of their CFSs, field isolates 3 and 5 were selected for
use in the cytotoxicity assays and in Western blot analyses.
Cytotoxic activities of CFSs on bovine PBMCs. The CFSs of
M. ovis field isolates 3 and 5, M. ovis ATCC 19575, and M. bovis
Epp63 demonstrated cytotoxic activities on bovine PBMCs,
with geometric mean titers ranging from 64 to 16 (data not
shown).
Effects of CFSs on bovine corneal epithelial cells. Exposure
of corneal cell monolayers to CFSs from M. ovis field isolates
3 and 5 and M. bovis Epp63 resulted in cell detachment and
complete loss of the cell monolayers within 2 h. The CFS from
M. ovis ATCC 19575, however, did not cause any noticeable
monolayer disruption or the loss of cells (Fig. 3).
SDS-PAGE and Western blot analysis of CFSs. The poly-
clonal primary antibody recognizes a cluster of repeats in toxin
(RTX) A proteins of M. bovis strain T (2). These antibodies
also recognized several proteins in the M. bovis Epp63 CFS
(Fig. 4, lane M. bovis Epp63). A cluster of strong bands mi-
grated at about 90 to 100 kDa, and another cluster migrated at
about 80 to 88 kDa. Several proteins were also detected in the
M. ovis CFS (Fig. 4). The distribution of bands in all M. ovis
lanes, however, was such that the more prominent bands mi-
grated at lower molecular masses. A single band of about 98
kDa recognized in the M. bovis CFS was also recognized in all
M. ovis CFSs. When preimmunization rabbit serum was used
as the primary antibody, no bands were seen (data not shown),
indicating that the bands detected by the anti-M. bovis serum
are due to a specific antigen-antibody reaction and are not due
to nonspecific binding of the antibody.
DISCUSSION
The results of this study indicate that M. ovis isolates recov-
ered from cattle with IBK produce one or more heat-labile
exotoxins that demonstrate hemolytic activity on bovine eryth-
rocytes and cytotoxic activity on bovine PBMCs and corneal
epithelial cells. The data indicate that, like the known virulent
isolate M. bovis Epp63 (12, 20, 21, 25, 27), the M. ovis isolates
tested also possess hemolytic and cytotoxic activities. The he-
molytic and cytotoxic activities of M. bovis are mediated by a
hemolysin, a calcium-dependent, pore-forming RTX (2, 5, 7,
12, 20). Although the definite nature of the toxic activities of
FIG. 2. Comparison of hemolytic activities of M. bovis and M. ovis
field isolates after heat treatment. Prior to the assay, the CFSs were
treated as described in the legend to Fig. 1, but heat-treated (light gray
bars) and non-heat-treated (dark gray bars) CFSs were run side by
side. Bars indicate the geometric mean titers of the hemolytic activities
of the CFSs from M. bovis Epp63 and two of the five M. ovis field
isolates (isolates 3 and 5), as in Fig. 1. Error bars represent the 95%
confidence intervals of the means. The results shown represent data
from three independent replications.
FIG. 3. Effects of CFSs on bovine corneal epithelial cell monolay-
ers. Monolayers of corneal epithelial cells were either not exposed to
any CFS (negative control) (A) or exposed to M. ovis ATCC 19575
CFS (B), exposed to M. ovis field isolates 3 (C) or 5 (D), or exposed to
M. bovis Epp63 CFS (positive control) (E). Note the complete disrup-
tion of the monolayers exposed to CFSs produced by field isolates 3
and 5 and M. bovis Epp63. The photomicrographs shown are repre-
sentative of three independent replications. Bar, 100 m.
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M. ovis CFSs has yet to be determined, it is possible, based on
the similarity of action, that these effects are mediated by an
exotoxin qualitatively similar to the M. bovis RTX. Substantial
attenuation of the hemolytic activity of the M. ovis CFS after
heat treatment also suggests that the presumptive M. ovis exo-
toxin is proteinaceous, like the M. bovis RTX. Based on the
observation that the titers of the M. bovis CFSs were slightly
higher in this assay, it may be speculated that the M. ovis
exotoxin is more readily inactivated. A similar tendency was
evident when CFSs were incubated at 4°C for 24 h before the
hemolysin assay was conducted. This difference could be due to
structural or conformational differences in the proteins or to
the activity of proteolytic enzymes released by M. ovis during
logarithmic growth (4, 18). The objective of this study, how-
ever, was to examine selected M. ovis field isolates for the
presence of potential virulence factors, and no attempt was
made to quantify the hemolytic or the cytotoxic activity.
The primary antibody used in the Western blot assay spe-
cifically recognized the M. bovis toxin, but it also recognized
several proteins in the M. ovis CFSs. A cluster of bands of
approximately 95 to 100 kDa may be significant because this
molecular mass is consistent with those of recognized RTXs
(18, 42), including M. bovis RTX A (1, 2). A single band in all
M. ovis CFSs migrated at this particular molecular mass, sug-
gesting some structural similarity. The identities of the several
lower-molecular-mass bands present in the M. ovis lanes are
unknown at this time. Other investigators have shown that
full-length RTXs degrade after only a few hours in culture, and
specific antibodies recognize several smaller degradation prod-
ucts (2, 18). If it is assumed that a toxin is present in the M. ovis
CFS, it is possible that those lower-molecular-mass bands rep-
resent the degradation products of a full-length toxin.
The M. ovis isolates examined in this study differed in their
hemolytic and cytotoxic activities. This may suggest that the
isolates are different strains, but no testing was done to deter-
mine if these isolates were indeed different strains. The num-
ber of animal passages of each of the M. ovis field isolates
received prior to laboratory isolation is unknown, and the
number of animal and laboratory passages of M. ovis ATCC
19575 is also unknown. Interestingly, M. ovis ATCC 19575 did
not exhibit any cytotoxicity to bovine corneal epithelial cells,
although toxicity to erythrocytes and peripheral blood mono-
nuclear cells was observed. Intraspecies variation (e.g., strain
differences), as suggested above, does not likely account for
these results. It has been shown for M. bovis that only piliated
isolates can adhere to bovine corneal epithelial cells (24, 29);
and it is possible, therefore, that isolate ATCC 19575 was not
piliated and could not adhere to the corneal cells to exert a
toxic effect. Some RTXs have been shown to specifically rec-
ognize and bind to a host cell receptor (15, 41), and it is also
possible that the presumptive hemolysin of the ATCC 19575
strain lacked this ability. It is also noteworthy that the ATCC
19575 isolate is of sheep origin, and a toxin produced during
passages in sheep may act on the cornea in a strictly species-
specific manner but may act more promiscuously on erythro-
cytes and PBMCs. The M. ovis isolates were not examined for
piliation, and the reasons for differences in activity between the
two M. ovis field isolates and the ATCC 19575 isolate remain
speculative.
Currently, piliated and hemolytic M. bovis isolates are
recognized as the etiologic agents of IBK. Data from the
Nebraska Veterinary Diagnostic Laboratory System, how-
ever, indicate that M. ovis is isolated from the majority of
cattle with IBK. From January 1999 through December
2002, samples from a total of 109 cases of IBK were received
at the Veterinary Diagnostic Center. In 79 cases (72.5%), M.
ovis was the only agent isolated, whereas in 18 cases
(16.5%), M. bovis was the only pathogen isolated. In 12
cases (11%), both M. ovis and M. bovis isolates were recov-
ered. Other investigators have isolated M. ovis from cattle
with IBK (17, 31), but experimental inoculation of calves
with M. ovis isolates did not cause keratoconjunctivitis in
one study (17). Although the M. ovis isolates in another
study exhibited hemolytic activity on blood agar (31), they
were not examined for cytotoxic activity or piliation. These
findings might suggest that M. ovis, if it is pathogenic, may
require initial corneal damage or other predisposing factors
to cause disease in cattle. Moraxella bovis isolates differ in
their virulence; some isolates readily cause disease experi-
mentally, while others require corneal damage to cause dis-
ease (11, 19, 34). Differences in virulence may also be a
common to M. ovis isolates. Since only piliated, hemolytic
isolates of M. bovis are pathogenic for cattle (35), pili may
also be necessary for M. ovis to attach to and colonize bovine
cornea and conjunctiva. This hypothesis should be further
addressed by using M. ovis field isolates from cattle. Al-
though the results of this study indicate that M. ovis field
isolates from cattle produce one or more exotoxins, further
characterization of this suspected M. ovis toxin and studies
that examine the piliation of field isolates and adherence of
M. ovis to the bovine cornea are necessary to substantiate
the potential role of M. ovis in the pathogenesis of IBK.
FIG. 4. Detection of M. ovis CFS proteins by Western blot analysis.
CFS proteins were separated by SDS-PAGE on a standard 10% poly-
acrylamide gel and then subjected to Western blot analysis. The pri-
mary antibody was anti-M. bovis rabbit serum. Molecular masses (in
kDa) are indicated on the left; the arrow denotes bands of about 98
kDa, the molecular mass recognized for different RTXs. The picture
shown is representative of three independent assays.
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